PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
Amer M Zeidan,
Amir Fathi,
Ghayas Issa,
Harry Erba,
Julie Ahsan Mackey,
Daniel Corum,
Blake Tomkinson,
Tom Kozlek,
Mollie Leoni,
Eunice Wang
Affiliations
Amer M Zeidan
1 Yale University, New Haven, United States
Amir Fathi
2 Massachusetts General Hospital, Boston, United States
Ghayas Issa
3 MD Anderson Cancer Center, Houston, United States
Harry Erba
4 Duke University Hospital, Durham, United States
Julie Ahsan Mackey
5 Kura Oncology, Inc, Boston, United States
Daniel Corum
6 Kura Oncology, Inc, Boston, United States
Blake Tomkinson
5 Kura Oncology, Inc, Boston, United States
Tom Kozlek
6 Kura Oncology, Inc, Boston, United States
Mollie Leoni
5 Kura Oncology, Inc, Boston, United States
Eunice Wang
7 Roswell Park Comprehensive Cancer Center, Buffalo, United States
